Dr. Srilatha Kothandaraman, M.D.
What this data tells you about Dr. Kothandaraman
Dr. Srilatha Kothandaraman is a rheumatology in Dallas, TX, with 15 years in practice. Based on federal Medicare data, Dr. Kothandaraman performed 111,835 Medicare services across 2,789 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kothandaraman received a total of $119,860 from 34 pharmaceutical and/or device companies across 1122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kothandaraman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 58,800 | $4 | $5 |
| Tocilizumab injection (Actemra) | 30,120 | $4 | $7 |
| Golimumab infusion (Simponi Aria) | 12,400 | $11 | $14 |
| Denosumab injection (Prolia/Xgeva) | 3,901 | $18 | $23 |
| Office visit, established patient (30-39 min) | 975 | $88 | $130 |
| Comprehensive metabolic blood panel | 778 | $10 | $12 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 746 | $4 | $5 |
| Complete blood count (CBC) with differential | 706 | $8 | $9 |
| C-reactive protein test (inflammation marker) | 607 | $5 | $6 |
| Blood draw (venipuncture) | 395 | $3 | $3 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 379 | $56 | $76 |
| Injection of additional new drug or substance into vein | 184 | $12 | $18 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 176 | $49 | $68 |
| Injection, methylprednisolone sodium succinate, up to 40 mg | 155 | $3 | $4 |
| Office visit, established patient, complex (40-54 min) | 138 | $115 | $182 |
| Vitamin D level test | 137 | $28 | $30 |
| Injection, diphenhydramine hcl, up to 50 mg | 124 | $1 | $1 |
| Administration of chemotherapy into vein, 1 hour or less | 114 | $96 | $142 |
| Injection of drug or substance into vein | 95 | $29 | $38 |
| Administration of chemotherapy into vein, each additional hour | 79 | $22 | $29 |
| Bone density scan (DEXA) | 62 | $38 | $51 |
| Automated urinalysis | 61 | $2 | $4 |
| Calculation of trabecular bone score (tbs) using imaging data with interpretation and report on fracture risk | 49 | $32 | $43 |
| X-ray of hand, 2 views | 47 | $24 | $32 |
| New patient office visit, complex (60-74 min) | 45 | $153 | $226 |
| Thyroid stimulating hormone (TSH) test | 43 | $16 | $18 |
| Complete blood count (CBC), automated | 43 | $6 | $7 |
| Ferritin level test (iron stores) | 37 | $13 | $14 |
| Iron level test | 35 | $6 | $6 |
| Iron binding capacity test | 35 | $9 | $9 |
| Vitamin B-12 level test | 32 | $15 | $15 |
| Folic acid level test | 32 | $14 | $15 |
| Measurement of complement (immune system proteins), antigen, | 32 | $12 | $12 |
| Measurement of complement function (immune system proteins) | 32 | $12 | $12 |
| X-ray of wrist, 2 views | 30 | $26 | $35 |
| X-ray of knee, 1-2 views | 30 | $25 | $40 |
| Thyroxine (thyroid chemical), total | 29 | $7 | $8 |
| Thyroid hormone evaluation | 29 | $6 | $9 |
| Creatine kinase (cardiac enzyme) level, total | 25 | $6 | $8 |
| Shoulder X-ray, 2+ views | 18 | $28 | $36 |
| Office visit, established patient (20-29 min) | 18 | $62 | $92 |
| Urinalysis with microscopic exam | 17 | $3 | $3 |
| Flu vaccine, high-dose | 16 | $69 | $70 |
| Flu vaccine administration | 16 | $17 | $17 |
| Uric acid level test | 13 | $4 | $5 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for rheumatology in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kothandaraman is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), and high industry engagement (speaking/promotional, top 6%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kothandaraman experienced with certolizumab injection (cimzia)?
Does Dr. Kothandaraman receive payments from pharmaceutical companies?
How do Dr. Kothandaraman's costs compare to other rheumatologys in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology